The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.

Schmidt, C J

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. [electronic resource] - European journal of pharmacology Feb 1995 - 273-9 p. digital

Publication Type: Journal Article

0014-2999

10.1016/0014-2999(94)00698-7 doi


3,4-Dihydroxyphenylacetic Acid--metabolism
Animals
Behavior, Animal--drug effects
Dopamine--metabolism
Electrophysiology
Fluorobenzenes--pharmacology
Homovanillic Acid--metabolism
In Vitro Techniques
Male
Microdialysis
Piperidines--pharmacology
Prefrontal Cortex--drug effects
Rats
Rats, Sprague-Dawley
Ritanserin--pharmacology
Serotonin Antagonists--pharmacology